Eli Lilly & Co.
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2006 | $15.69B | — | — |
| FY2007 | $18.63B | $3.88B | $2.95B |
| FY2008 | $20.37B | $-1.54B | $-2.07B |
| FY2009 | $21.84B | $5.62B | $4.33B |
| FY2010 | $23.08B | $6.95B | $5.07B |
| FY2011 | $24.29B | $6.32B | $4.35B |
| FY2012 | $22.60B | $5.08B | $4.09B |
| FY2013 | $23.11B | $6.05B | $4.68B |
| FY2014 | $19.61B | $3.15B | $2.39B |
| FY2015 | $19.96B | $2.95B | $2.41B |
| FY2016 | $21.22B | $3.56B | $2.74B |
| FY2017 | $22.87B | $2.53B | $-204.1M |
| FY2018 | $21.49B | $3.92B | $3.23B |
| FY2019 | $22.32B | $5.67B | $8.32B |
| FY2020 | $24.54B | $7.59B | $6.19B |
| FY2021 | $28.32B | $6.50B | $5.58B |
| FY2022 | $28.54B | $7.14B | $6.24B |
| FY2023 | $34.12B | $7.04B | $5.24B |
| FY2024 | $45.04B | $12.68B | $10.59B |
| FY2025 | $65.18B | $25.73B | $20.64B |